BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 22, 2005
View Archived Issues
NXL-101 found effective against multidrug resistant S. aureus strains
Read More
AQ4N shows preclinical promise for ALL
Read More
DZ-697b: antithrombotic activity presented
Read More
Critical Therapeutics cleared for phase I/II study of intravenous zileuton
Read More
Dosing begins in new phase Ib study of DOV-21947
Read More
First phase III trial begins for HCT-3012 in osteoarthritis of the knee
Read More
Novartis selects preclinical development candidate in Vernalis collaboration
Read More
IND filed for PulmoLAR for PAH
Read More
Nabi Biopharmaceuticals closes operations in Europe
Read More
Fast track designation for C1-INH in hereditary angioedema
Read More
Memory signs agreement for development of MEM-1003 for bipolar disorder
Read More
XL-999 enters phase II development
Read More
Novelix licenses cancer therapeutics from the U. of Southern California
Read More
Positive results of synDNA hepatitis B vaccine study
Read More
Callisto looks back on 2005 achievements
Read More
CuraGen and Bayer amend terms in metabolic disorder collaboration
Read More
Dyax and Debiopharm restructure development agreement for DX-890
Read More
New galanin-3 receptor antagonists for depression and anxiety
Read More
PKCbeta inhibition with enzastaurin effective treatment for relapsed diffuse large B-cell lymphoma
Read More
MEM-1003 is cognitively safe in patients with Alzheimer's disease
Read More
Nexavar receives FDA approval for advanced renal cell carcinoma
Read More
New data on vicriviroc presented at ICAAC
Read More
RWJ-417457: A novel antibacterial in early clinical development
Read More
AstraZeneca presents data on oxazolidinone-based antibacterial agents
Read More
Compounds demonstrating activity against HIV disclosed in recent patent literature
Read More
New agents with potential for the treatment of thrombotic disorders reported
Read More
PKC inhibitors for transplant rejection claimed in Novartis patent
Read More
KOS-953 alone and with bortezomib investigated in multiple myeloma
Read More
AT-101 demonstrates significant preclinical activity in MM, CLL and aggressive lymphoma
Read More